Vimarsana
Biggest News Aggregation in the World

Page 2 - Jackd Bui News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Jackd Bui. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Jackd Bui Today - Breaking & Trending Today

Cancer-fighting immune cells can fuel their ability to attack tumors - Vimarsana News

Cancer-fighting immune cells can fuel their ability to attack tumors

When you need a bit of motivation, it often has to come from within. New research suggests cancer-fighting immune cells have found a way to do just that.

T cells can activate themselves to fight tumo - Vimarsana News

T cells can activate themselves to fight tumo

UC San Diego scientists find an auto-signaling mechanism driving the T cell anti-tumor response; findings may inspire new cancer therapeutics and biomarkers.

T cells can activate themselves to fight tumours: Research - Vimarsana News

T cells can activate themselves to fight tumours: Research

When it comes to motivation, it is often necessary to look within

T cells can activate themselves to fight tumours: Research - Vimarsana News

T cells can activate themselves to fight tumours: Research

When it comes to motivation, it is often necessary to look within. According to new research, cancer-fighting immune cells have discovered a way to do just that

Paramita Therapeutics, Inc. Awarded Competitive Grant From the National Science Foundation - Vimarsana News

Paramita Therapeutics, Inc. Awarded Competitive Grant From the National Science Foundation

 grant  for  $255,990 to conduct research and development work on a novel dual-function therapeutic/vaccine product, designated as TheraVax™. TheraVax not only can block entry of SARS-CoV-2 but also can activate the immune system to produce effector T cells and neutralizing antibodies to eliminate SARS-CoV-2. This unique dual-function therapeutic/vaccine could work at an early stage of infection to prevent hospitalization and in mild or severe disease to block viral spread while activating appropriate immune responses.   "NSF is proud to support the technology of the future by thinking ...